1 |
King AD, Ahuja AT, Leung SF, et al. Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease. Head Neck 2000;22:275-81.
DOI
|
2 |
Wang X, Li L, Hu C, et al. Patterns of level II node metastasis in nasopharyngeal carcinoma. Radiother Oncol 2008;89:28-32.
DOI
|
3 |
Gao Y, Zhu G, Lu J, et al. Is elective irradiation to the lower neck necessary for N0 nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys 2010;77:1397-402.
DOI
|
4 |
Zeng L, Sun XM, Chen CY, et al. Comparative study on prophylactic irradiation to the whole neck and to the upper neck for patients with neck lymph node-negative nasopharyngeal carcinoma. Head Neck 2014;36:687-93.
DOI
|
5 |
Li JG, Yuan X, Zhang LL, et al. A randomized clinical trial comparing prophylactic upper versus whole-neck irradiation in the treatment of patients with node-negative nasopharyngeal carcinoma. Cancer 2013;119:3170-6.
DOI
|
6 |
Chen JZ, Le QT, Han F, et al. Results of a phase 2 study examining the effects of omitting elective neck irradiation to nodal levels IV and Vb in patients with N(0-1) nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2013;85:929-34.
DOI
|
7 |
Pow EH, Kwong DL, Sham JS, Lee VH, Ng SC. Can intensitymodulated radiotherapy preserve oral health-related quality of life of nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys 2012;83:e213-21.
DOI
|
8 |
National Comprehensive Cancer Network. Head and neck cancers version v.1.2015 [Internet]. Fort Washington, PA: National Comprehensive Cancer Network; c2015 [cited 2016 Mar 17]. Available from: http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf.
|
9 |
Fletcher GH, Million RR. Malignant tumors of the nasopharynx. Am J Roentgenol Radium Ther Nucl Med 1965;93:44-55.
|
10 |
Korea Central Cancer Registry, National Cancer Center. Annual report of cancer statistics in Korea in 2012. Goyang: Ministry of Health and Welfare; 2014.
|
11 |
Sham JS, Choy D, Wei WI. Nasopharyngeal carcinoma: orderly neck node spread. Int J Radiat Oncol Biol Phys 1990;19:929-33.
DOI
|
12 |
Tang L, Mao Y, Liu L, et al. The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma: analysis of the spread patterns in lymph nodes by magnetic resonance imaging. Cancer 2009;115:680-8.
DOI
|
13 |
Ho FC, Tham IW, Earnest A, Lee KM, Lu JJ. Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a metaanalysis of clinical evidence. BMC Cancer 2012;12:98.
DOI
|
14 |
Lee AW, Ng WT, Hung WM, et al. Major late toxicities after conformal radiotherapy for nasopharyngeal carcinomapatient-and treatment-related risk factors. Int J Radiat Oncol Biol Phys 2009;73:1121-8.
DOI
|
15 |
Lee AW, Sham JS, Poon YF, Ho JH. Treatment of stage I nasopharyngeal carcinoma: analysis of the patterns of relapse and the results of withholding elective neck irradiation. Int J Radiat Oncol Biol Phys 1989;17:1183-90.
DOI
|
16 |
Al-Sarraf M, LeBlanc M, Giri PG, et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 1998;16:1310-7.
DOI
|
17 |
Wee J, Tan EH, Tai BC, et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol 2005;23:6730-8.
DOI
|
18 |
Sung SY, Kang MK, Kay CS, et al. Patterns of care for patients with nasopharyngeal carcinoma (KROG 11-06) in South Korea. Radiat Oncol J 2015;33:188-97.
DOI
|
19 |
van den Brekel MW, Stel HV, Castelijns JA, et al. Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 1990;177:379-84.
DOI
|
20 |
Dawson LA, Anzai Y, Marsh L, et al. Patterns of localregional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2000;46:1117-26.
DOI
|
21 |
Lee N, Harris J, Garden AS, et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol 2009;27:3684-90.
DOI
|
22 |
Lee NY, Zhang Q, Pfister DG, et al. Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multiinstitutional trial. Lancet Oncol 2012;13:172-80.
DOI
|
23 |
Sham JS, Cheung YK, Choy D, Chan FL, Leong L. Computed tomography evaluation of neck node metastases from nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1993; 26:787-92.
DOI
|
24 |
Abdel Khalek Abdel Razek A, King A. MRI and CT of nasopharyngeal carcinoma. AJR Am J Roentgenol 2012;198:11-8.
DOI
|
25 |
King AD, Ma BB, Yau YY, et al. The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis. Br J Radiol 2008;81:291-8.
DOI
|